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Abstract 
Background: Tobacco consumption is a major risk factor for many diseases including diabetes and has deleterious 
effects on oral health. Diabetic patients are vulnerable to developing certain oral conditions. So far, no studies have 
attempted to co-develop a tobacco cessation intervention to be delivered in dental clinics for people with diabetes in 
Bangladesh.
Aim: To co-produce a tobacco cessation intervention for people with diabetes for use in dental clinics in Bangladesh.
Objectives: To assess: (1) tobacco use (patterns) and perceptions about receiving tobacco cessation support from 
dentists among people with diabetes attending the dental department of Bangladesh Institute of Research and 
Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM) who smoke or use smokeless tobacco (ST) 
(2) current tobacco cessation support provision by the dentists of the dental department of BIRDEM (3) barriers and 
facilitators of delivering a tobacco cessation intervention at a dental clinic, and (4) to co-produce a tobacco cessation 
intervention with people with diabetes, and dentists to be used in the proposed context.
Methods: The study was undertaken in two stages in the dental department of BIRDEM, which is the largest diabetic 
hospital in Bangladesh. Stage 1 (July–August 2019) consisted of a cross-sectional survey among people with diabetes 
who use tobacco to address objective 1, and a survey and workshop with dentists working in BIRDEM, and consul-
tations with patients to address objectives 2 and 3. Stage 2 (January 2020) consisted of consultations with patients 
attending BIRDEM, and a workshop with dentists to co-produce the intervention.
Result: All survey participants (n = 35) were interested in receiving tobacco cessation support from their dentist. 
We identified important barriers and facilitators to deliver tobacco cessation intervention within dental services. 
Barriers reported by dentists included lack of a structured support system and lack of training. As a facilitator, we 
identified that dentists were willing to provide support and it would be feasible to deliver tobacco cessation interven-
tion if properly designed and embedded in the routine functioning of the dental department of BIRDEM. Through 
the workshops and consultations at stage 2, a tobacco cessation intervention was co-developed. The intervention 
included elements of brief cessation advice (using a flipbook and a short video on the harmful effects of tobacco) and 
pharmacotherapy.
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Introduction
Tobacco (both smoking and smokeless) use is a known 
risk factor for many chronic diseases, posing major 
health challenges and economic burden [1]. Smoking has 
been recognized as one of the biggest risk factors for oral 
diseases such as periodontitis (disease of tooth-support-
ing bone and soft tissue) and tooth loss [2, 3] Smoking 
accelerates periodontitis and reduces the response to 
dental treatment [4], as it impairs the periodontal tissue’s 
ability to heal [5]. Smoking also causes discolouration of 
teeth and bad breath [6]. Smokeless tobacco (ST), par-
ticularly chewing tobacco, is also harmful for oral health. 
ST (particularly that consumed in South-East Asia 
(SEA)) contains harmful chemicals like tobacco-specific 
N-nitrosamines (TSNAs) [7], which are known risk fac-
tors for oral cancers and also increase the risk of different 
oral lesions, including potentially malignant disorders [8, 
9].
Globally, 463 million people have diabetes and the 
majority of them are from the SEA region [10]. Diabetes 
is a major health challenge in SEA [11], with a regional 
prevalence of 8.8% of adults [12]. People with diabetes are 
more prone to certain oral diseases [13]. A review showed 
a higher prevalence of oral mucosal disorders in people 
with diabetes (45–88%) compared with the non-diabetic 
population (38–45%) [14]. Periodontitis is considered as 
the sixth most common complication of diabetes [15]. 
Evidence suggests that there is bidirectional association 
between periodontal disease and diabetes mellitus [16–
19]. Treating periodontal disease can be influential in 
contributing to glycaemic control and vice versa [17]. As 
tobacco use increases the risk of both diabetes and oral 
diseases, tobacco cessation is particularly important in 
improving the general and oral health of people with dia-
betes. A review of more than 200 studies concluded that 
there is a clear need to increase the frequency of smoking 
cessation advice and counselling for people with diabetes 
[20]. The National Diabetes Education Program under 
CDC has identified specific providers, including dentists, 
to work together through interdisciplinary collabora-
tion and to implement evidence-based strategies to ask, 
advise, and assist patients in reducing their risk behaviors 
and encouraging healthy behaviors, such as smoking ces-
sation [21]. It is therefore important to offer tobacco ces-
sation support to people with diabetes who use tobacco 
by using a tailored tobacco cessation intervention as part 
of their routine dental care.
People who are diagnosed with oral lesions or 
advanced periodontitis worry about developing oral 
cancer or losing their teeth and this can then lead them 
to alter their health behaviours positively [22]. This is 
known as a ‘teachable moment’. Dental professionals can 
use this opportunity to offer tobacco cessation advice 
[23], although this opportunity is rarely taken [24]. A 
systematic review by Holliday et al. (2021) provided evi-
dence with moderate-certainty that tobacco abstinence 
rates increase in cigarette smokers if dental profession-
als offer behavioural support in conjunction with the 
provision of nicotine replacement therapy (NRT) or 
e-cigarettes, when compared with no intervention, usual 
care, or brief, or very brief advice only (RR 2.76, 95% CI 
1.58–4.82) [25]. Interventions in the dental setting usu-
ally included a multi-component tobacco cessation inter-
ventions in conjunction with an oral examination [26]. 
Interventions included behavioural support in the form 
of brief advice, in combination with different interven-
tion components such as video-based tobacco cessation 
with phone follow up [27–29], or referral to a quitline 
[30]. Some studies included the 5 A’s intervention (ask, 
advise, assess, assist, and arrange counselling with quit-
line referral as an option at the provider’s discretion). 
Some studies included the 3 A’s (ask, advise, arrange quit-
line referral) [31], counselling using the 5 A’s plus NRT 
[32], brief ’tailored’ tobacco advice, assistance using pop-
ulation-specific printed material and NRT [33]. Evidence 
also showed that behavioural support interventions were 
effective in improving oral health-related behaviours [34]. 
Incorporation of tobacco cessation into dental care would 
provide a unique opportunity for supporting people with 
diabetes to stop their tobacco use. However, such a facil-
ity is very limited in SEA.
Bangladesh is a country in SEA with a high prevalence 
of diabetes in adults (8.1%). The International Diabetes 
Federation estimated that 7.1 million people in Bang-
ladesh live with diabetes and almost the same number 
have undetected diabetes [35]. A recent Global Adult 
Tobacco Survey (GATS) showed that the prevalence 
of tobacco use is high in Bangladesh (18% are smok-
ers and 20.6% are ST users) [36]. The level of addiction 
for ST is high among users [37]. A study estimated that 
34% of people with diabetes use tobacco in Bangladesh 
[38]. Oral diseases are also common among people with 
diabetes in this country [39]. The increasing prevalence 
of diabetes and oral diseases, along with high levels of 
Conclusion: Incorporation of tobacco cessation within dental care for people with diabetes was considered feasible 
and would provide a valuable opportunity to support this vulnerable group in quitting tobacco.
Keywords: Diabetes, Dental care, Barriers, Facilitators, Tobacco cessation, Intervention, Co-production
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tobacco consumption pose major health challenges in 
Bangladesh. Furthermore, Bangladesh has no dedicated 
national tobacco cessation service or quitline [40]. Bang-
ladesh Institute of Research and Rehabilitation for Dia-
betes, Endocrine and Metabolic Disorders (BIRDEM) is 
the largest hospital in Bangladesh and is a tertiary hos-
pital with more than 650 beds [41]. People with diabetes 
from all over the country receive their treatment here. 
BIRDEM has a dental outpatient department that serves 
almost 70 patients each day. A tobacco cessation inter-
vention, delivered by dental health professionals in the 
dental department of BIRDEM, integrated with messages 
to improve oral hygiene could help people with diabetes 
quit tobacco and improve their oral health.
Whilst there is currently no evidence of the use of 
these strategies in a dental setting in Bangladesh with 
people with diabetes who use tobacco, evidence from 
other routine health-care settings such as tuberculosis 
(TB) programmes delivered in primary and secondary 
care has shown that behavioural support delivered by 
health workers with one day of training in tobacco ces-
sation, using flipbooks, leaflets and posters was effective 
in achieving quit rates of 41% at 6 months among people 
attending TB clinics. This was 4% more effective when 
combined with pharmacological treatments for cessation 
[42]. A further study in Bangladesh and Pakistan among 
TB patients attending healthcare facilities found 25% 
of people quit at 12  months following brief behavioural 
advice [43]. It has also been shown that a behavioural 
change intervention using a flipbook was acceptable 
and feasible to deliver in the SEA setting for ST cessa-
tion [44]. The flipbook consisted of messages based on 
behaviour change techniques proven to be effective for 
helping people quit smoking following several stages of 
behaviour change based on the trans-theoretical model 
(pre-contemplation, contemplation, preparation, action, 
and maintenance) [45, 46]. People changing their smok-
ing behaviour focus on different processes at particular 
stages of change. For example, they use the fewest pro-
cesses of change during precontemplation; and empha-
size raising their consciousness during the contemplation 
stage. They emphasize self-re-evaluation in both the con-
templation and action stages; emphasize self-liberation, 
a helping relationship, and reinforcement management 
during the action stage; and use counterconditioning and 
stimulus control in both action and maintenance stages 
[47]. In the general population, behavioural support 
combined with pharmacotherapy is the most effective 
strategy in helping people to quit smoking [48–50]. No 
pharmacological therapies, including NRT, are routinely 
available in Bangladesh, nor has any behavioural change 
intervention been developed that is tailored to people 
with diabetes who use tobacco. Therefore, developing 
such an intervention could be highly beneficial for this 
population.
When developing a public health intervention, it is vital 
to engage with the end users and all key stakeholders [51, 
52]. Co-production gives the opportunity for the end 
user to directly shape the intervention and empowers the 
public to contribute to and draw on research to improve 
their lives. Co-production increases the involvement of 
the ultimate beneficiaries and end users of research from 
the very beginning of the research process. This has the 
potential to produce stronger research, and research out-
comes that better fit the needs, values and interests of 
end users [53, 54]. Therefore, co-production of a tobacco 
cessation intervention including adaptation of existing 
intervention materials to suit a dental setting could be 
beneficial for this vulnerable group.
The aim of this study was to co-produce a tobacco ces-
sation intervention for people with diabetes for use in 
dental clinics in Bangladesh. The study had four objec-
tives, as follows:
1. To assess tobacco use (patterns) and perceptions 
about receiving tobacco cessation support from den-
tists among people with diabetes attending the dental 
department of BIRDEM who smoke or use ST.
2. To assess the status of any current tobacco cessation 
support provision by the dentists at BIRDEM.
3. To assess the barriers and facilitators of implement-
ing a tobacco cessation intervention at BIRDEM.
4. To co-produce a tobacco cessation intervention with 
people with diabetes, and dentists to be used in the 
proposed context.
Methods
The study was undertaken in the Department of Den-
tistry at BIRDEM in Dhaka, Bangladesh. Ethics approval 
was obtained from the Ethical Review Committee (ERC) 
of the Diabetic Association of Bangladesh (BADAS). 
According to phase 1 of the MRC framework for devel-
oping and evaluating complex interventions [55], we co-
produced the tobacco cessation intervention materials 
(reported in this paper), with our long-term aim being 
to test the developed intervention for feasibility, effec-
tiveness and cost-effectiveness (Phases 2–4 of the MRC 
framework) at a later stage. The study was conducted 
in two stages adapted from the standard steps of co-
production recommended by Hawkins et  al. [56]. Stage 
1 (related to objective 1, 2 and 3) included surveys, and 
consultation with people with diabetes attending BIR-
DEM and workshop with dentists; stage 2 (related to 
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objective 4) involved co-production of the intervention 
materials (Fig. 1).
Patient and Public Involvement (PPI) activity was 
embedded at each stage to work collaboratively with the 
end users and dentists. The research question was devel-
oped and informed by the needs and priorities of both 
key stakeholder groups.
Stage 1
To assess tobacco use patterns and perceptions of peo-
ple with diabetes on receiving tobacco cessation support 
from the dentists, a cross-sectional questionnaire sur-
vey was administered between July and August 2019. All 
people with diabetes (clinically diagnosed as diabetic and 
registered in BIRDEM) who attended for dental treat-
ment and reported using tobacco were approached to 
participate in the survey within the two-month data col-
lection period. The survey was conducted among people 
who agreed to participate. The survey was conducted 
anonymously, after informed consent was obtained from 
all participants. The tobacco use questions were adapted 
from GATS in Bangladesh [36]. Other study specific 
questions were developed for this study.
To assess the barriers and facilitators of implementing 
a tobacco cessation intervention, one-to-one consulta-
tion was conducted with fifteen people with diabetes 
who use tobacco. A separate workshop was conducted 
with twenty-five dentists of BIRDEM to discuss their 
views about the barriers and facilitators to delivering the 
tobacco cessation intervention in the dental outpatient 
department of BIRDEM. Verbal consent was obtained 
before they participated in the workshop. Notes were 
taken during the consultation and workshop, and these 
were summarized in a report. To assess the current 
tobacco cessation support provision by dentists in this 
setting, the dentists completed an anonymous question-
naire that was adapted from the National Centre for 
Smoking Cessation and Training [57] questionnaire for 
Health Professionals, translated into Bengali. The survey 
data were analysed using descriptive statistics for the first 
two objectives. Identification of barriers and facilitators 
addressed the third objective.
•Objecve 1
• To assess tobacco use (paerns) and percepons about 
receiving tobacco cessaon support from densts among 
people with diabetes aending the dental department of 
BIRDEM who smoke or use ST
Stage 1
A cross-seconal quesonnaire survey among people 
with diabetes who use tobacco and aend the 
dental clinic and BIRDEM
•Objecve 2
• To assess the status of any current tobacco cessaon 
support provision by the densts at BIRDEM
Stage 1
A cross-seconal quesonnaire survey among the 
densts of BIRDEM
•Objecve 3
• To assess barriers and facilitators of implemenng a 
tobacco cessaon intervenon in the proposed site
Stage 1
* One to one consultaon with fi­een people with 
diabetes who use tobacco 
* A workshop with twenty five densts of BIRDEM
•Objecve 4
• To co-produce the tobacco cessaon intervenon with 
people with diadetes, and densts to be used in the 
proposed context
Stage 2
* One to one consultaon with ten people with 
diabetes who use tobacco .
* A workshop with eighteen densts of BIRDEM
* One to one consultaon with five people with 
diabetes who use tobacco.
* One to one consultaon with fivepeople with 
diabetes who use tobacco on video.
Fig. 1 Study objectives and related activity
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Stage 2
The second stage of the study was informed by the find-
ings of the first stage and included iterative consultations 
with patients and a workshop with the dentists (related to 
the 4th study objective). The aims of these activities were 
to co-produce the intervention and to outline the training 
materials for the dentists and dental nurses. The activities 
of the second stage were conducted in January 2020.
The consultations to co-produce the tobacco cessation 
intervention included one to one discussion about the 
intervention components and delivery with ten people 
with diabetes from BIRDEM who use tobacco. They were 
asked what support they would like to get from the dental 
professionals that could help them to stop using tobacco. 
We planned to develop a brief advice-based tobacco ces-
sation intervention to be delivered by dentists or dental 
nurses, as suggested by our study participants and sup-
ported by information in the literature. To facilitate the 
consultations, a draft template of a flipbook with different 
intervention components was shown to them to provoke 




Sex Male 20 (57.1)
Female 15 (42.9)
Age 29–50 years 13 (39.4)
51–70 years 20 (60.6)




Occupation Service 6 (17.1)
Household work 14 (40)
Retired and Unemployed 15 (42.8)
Tobacco use and attitude towards tobacco quitting
Tobacco use Cigarette 8 (22.9)
Smokeless tobacco 20 (57.1)
Dual use 7 (20)
Tobacco use pattern Daily use 27 (79.4)
Sometimes 7 (20.6)
Importance of tobacco cessation No 3 (10)
Moderately important 11 (35.5)
Important 7 (22.6)
Very important 10 (32.3)
Want to quit tobacco No 6 (17.1)
Yes, moderate 17 (48.6)
Yes, a lot 12 (34.3)
Worried about the expense of tobacco No 23 (65.7)
Yes, moderate 8 (22.9)
Yes, a lot 4 (11.4)
Worried about the health effects of tobacco No 10 (35.7)
Yes, moderate 12 (42.9)
Yes, a lot 6 (21.4)
Feel it’s difficult to quit No 17 (48.6)
A little 11 (31.4)
A lot 7 (20)
Tried to quit in last 12 months Yes 26 (74.3)
No 9 (25.7)
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their ideas and obtain their feedback. We adapted the 
template from theory-based behaviour change interven-
tions on smoking [43] and smokeless tobacco use among 
South Asians [44].
A workshop with the dentists working at BIRDEM was 
undertaken to prioritise messages for the tobacco cessa-
tion behaviour support intervention integrated with oral 
hygiene messages (based on feedback from the partici-
pants with diabetes who use tobacco). The workshop also 
outlined the culturally and contextually suitable inter-
vention components and plans to deliver the interven-
tion in routine dental practice. In this workshop, dentists 
were asked to respond to the following points for each 
key message: dentists’ perception of the acceptability to 
patients; acceptability for the dentists and dental nurses 
to discuss with patients; perceived effectiveness in help-
ing patients to quit; and feasibility to deliver. They also 
decided whether each key message should be kept in the 
behaviour support advice to the patients and training to 
the dentists and dental nurses or covered in training only 
but not in the advice session or excluded completely. The 
participants responded yes/ no for each aspect. The plan-
ning of incorporating the intervention within the regular 
workload, and the potential for incorporation of NRT 
along with behavioural support were also discussed.
Further refining of the intervention material was con-
ducted with the participants who have diabetes and use 
tobacco. One to one consultation with another five par-
ticipants was conducted to show them the intervention 
materials and obtain their feedback. For the feedback 
on the delivery plan, a hypothesized study scenario 
was described, and open questions were used to elicit 
their response to the delivery plan and invite sugges-
tions. A short video on the harmful effects of tobacco 
was also created, following suggestions from most of 
the participants. We received feedback on the short 
video via consultation with another five participants. 
The consultation with the patients was analysed focus-
ing on what they thought would work and what would 
not, and ways to further improve the design. Based on 
the feedback, we created a tobacco cessation interven-
tion, which combined a behaviour change intervention 
and pharmacotherapy (NRT). The behaviour change 
intervention included brief advice using a flipbook, and 
a short video on the harmful effects of tobacco. We also 
mapped the major behaviour change techniques (BCTs) 
with the potential mechanism of action of the key 
intervention components in the intervention package 
(based on different stages of behavior change follow-
ing the ‘transtheoretical model’). BCTs were numbered 
based on the theory and technique tool [58].
Results
Stage 1
A total of 35 people with diabetes who use tobacco and 
attend the dental outpatient clinic at BIRDEM (20 male 
and 15 female) completed the survey. Among those eight 
were cigarette smokers, 20 ST users and 7 dual users. The 
demographic characteristics of the participants and their 
tobacco use are presented in Table 1.
Table 2 Perception on receiving tobacco cessation support from dentists (N, max = 35)
Categories n (%)
If the doctor asked about tobacco use in the past 12 months? No 20 (57.1)
Yes 15 (42.9)
If the doctor gave advice for tobacco cessation past 12 months? No 20 (57.1)
Yes 15 (42.9)
Would you like it if the dentist asked about your tobacco use? No 0
Yes 35 (100)
Would you like it if the dentist gave you short advice on tobacco cessation? No 0
Yes 35 (100)
Would you like it if you are requested to set a quit date after giving advice? No 9 (25.7)
Yes 26 (74.3)
Would you like it if continuous help/support is provided to you for successful quitting? No 3 (8.8)
Yes 31 (91.2)
Would you like if telephone contact is made with you regarding tobacco cessation No 11 (31.4)
Yes 24 (68.6)
If you were asked to come again to the dentist in 3 months or 6 months’ time regarding follow-up of tobacco 
cessation, would you like it?
No 14 (40)
Yes 21 (60)
Would you like it if you were advised to take a medicine to make tobacco cessation successful? No 12 (34.3)
Yes 23 (65.7)
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Their perception about receiving tobacco cessation 
support from dentists indicated that all participants 
would like to be asked about their tobacco use and 
receive support from their dentist about tobacco cessa-
tion (Table 2).
A total of 25 dentists took part in the workshop and 
18 (72%) of them considered it was important to provide 
tobacco cessation advice and support, along with oral 
hygiene instruction to improve the oral health of people 
with diabetes. Seven (28%) of them disagreed with that. 
Currently, 11 (44%) of the dentists always asked their 
patients about tobacco use and 12 (48%) always advised 
them about quitting. However, they did not provide any 
further support. More than 85% did not use any struc-
tured or evidence-based approach such as following a 
flipbook or leaflets or other materials to support their 
patients to quit tobacco (Table 3).
The initial consultation and workshop reflected that 
the proposed tobacco cessation intervention delivered 
within a dental setting in BIRDEM was considered to be 
important and acceptable by potential end users (peo-
ple with diabetes who use tobacco and attend the dental 
department at BIRDEM). The opportunities and barriers 
identified by both potential end users and dentists are 
listed in Table  4. In short, willingness of the dentists to 
help their patients on tobacco cessation and willingness 
of the patients to receive relevant help from their dentists 
were identified as the main opportunities. However, not 
having enough time, and gaps in skills to counsel patients 
in tobacco cessation, and insufficient resources to sup-
port patients in tobacco cessation, were identified as the 
main barriers.
Stage 2
The co-production activity involved brief advice using 
a flipbook and video1, in combination with pharmaco-
therapy as this was the intervention that the dentists 
and potential end users thought would work best in 
Table 3 The current tobacco cessation support provision by dentists in the site (N, max = 25)
Categories n (%)
How much do the dentists agree with each of the following statements? (1–4)
1. I think it is important to provide tobacco cessation advice and support along with oral hygiene instruction to 
improve the oral health condition of the diabetic population
Disagree 7 (28)
Moderately agree 5 (20)
Completely agree 13 (52)
2. With my patients, I always discuss the effects of tobacco on health Disagree 4 (16)
Moderately agree 9 (36)
Completely agree 12 (48)
3. With my patients, I always discuss the effects of tobacco on oral health Disagree 7 (28)
Moderately agree 5 (20)
Completely agree 13 (52)
4. I have enough time and capacity to provide face-to-face tobacco cessation intervention Disagree 7 (28)
Moderately agree 14 (56)
Completely agree 4 (16)
5. I ask my patients about their tobacco use Always 11 (44)
Sometimes 13 (52)
Never 1 (4)
6. I recommend patients to stop using tobacco products Always 12 (48)
Sometimes 12 (48)
Never 1 (4)
7. In my centre, I offer help to patients who want to quit tobacco use Always 10 (40)
Sometimes 9 (36)
Never 6 (24)
8. Do you use any flipbooks or leaflets or other materials to support patients with oral hygiene instruction Always 1 (4)
Sometimes 4 (16)
Never 20 (80)
9. Do you use any flipbooks or leaflets or other materials to support patients to quit tobacco? Always 0
Sometimes 3 (14.3)
Never 18 (85.7)
1 https:// www. york. ac. uk/ healt hscie nces/ resea rch/ public- health/ proje cts/ 
tcdc/ tcdc- curre nt- work/.
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the dental setting. The key intervention components 
identified be included in the flipbook were: identifying 
the tobacco products that the patients use; specifying 
harmful ingredients; emphasizing the adverse health 
effects of tobacco of tobacco (specifically focusing 
on the impact of tobacco on oral health, the effect of 
tobacco on the person’s general health including dia-
betes); listing the benefits of quitting; dispelling mis-
conceptions/myths; using an ‘importance to quit’ scale; 
identifying triggers and coping strategies; planning and 
preparation; establishing readiness to quit; address-
ing withdrawal symptoms; incorporation of cessation 
medication along with the behaviour change tech-
niques; and addressing patients’ expectations of cessa-
tion medication. In addition, the intervention included 
oral hygiene instruction. We received positive feedback 
from the potential end users on the short video (2 min 
long). They understood the key message of this video 
about the harmful effects of tobacco on health and 
found it educational. They found the video motivating 
to quit tobacco and suggested incorporating that along 
with the flipbook during the first face-to-face advice. 
The key intervention components with potential mech-
anism of action are shown in Table 5 where BCTs were 
numbered based on the theory and technique tool.
Discussion
The survey results of the people with diabetes attend-
ing BIRDEM showed that the majority were smokeless 
tobacco users, and all were willing to get support for 
tobacco cessation from their dentist. Whilst a high pro-
portion of dentists reported that they asked and provided 
advice about tobacco use, the advice was limited to tell-
ing their patients to quit, with no further behavioural 
support or pharmacological interventions to help.
The workshop discussion with the dentists indicated 
that most did not have access to any resources such as 
flipbooks, leaflets or other materials, nor did they have 
appropriate knowledge of techniques to help and sup-
port patients to quit using tobacco, but they were will-
ing to provide support. The consultation with potential 
end users of the intervention and the workshop with the 
dentists revealed some important facilitators and barriers 
that need to be considered when developing the interven-
tion. Our study reflected that one of the main barriers of 
tobacco cessation intervention in the dental setting was 
lack of time (due to the provision of treatment to a large 
caseload of patients, dedicating sufficient time to engage 
in meaningful tobacco cessation consultation becomes 
infeasible). Lack of resources and training for dentists 
was identified in our study as another major challenge for 
Table 4 Barriers and facilitators identified by dentists and patients for tobacco cessation intervention for diabetic patients at the 
dental department of BIRDEM
Barriers Facilitators
Dentists’ perspective 1. Not having enough time to spend with the patient to give 
full behaviour change support on tobacco cessation due to 
work pressure
1. Willingness to help the patients on tobacco cessation
2. Not having clear knowledge on how to support a patient in 
tobacco cessation successfully
2. Willingness to learn how they can support their patients on 
tobacco cessation
3. Not having a clear understanding of behavioural change 
theory and interventions
3. Willingness to learn about behavioural change theory and 
interventions
4. Not having clear knowledge on nicotine replacement 
therapy (NRT) and prescribing rules for NRT
4. Willing to learn about NRT for tobacco cessation
5. No formal structure to take tobacco history from patients 5. Reputed hospital and doctors
6. No regular/ standard support structure to provide informa-
tion on harmful effects of tobacco
6. Teachable moment
7. No regular/ standard support structure for tobacco cessation 
available
7. As the patients are registered patients with diabetes, it 
would be possible to track them. Most attend follow-up dental 
appointments
Patients’ perspective 1. Lack of knowledge of harmful effects of tobacco
2. Misperceptions: believe that ST makes teeth strong
3. Long time addiction; they will find it difficult to quit and 
relapse when they face negative symptoms while trying to 
quit
4. Not interested in quitting (especially ST)
5. Have only short time to receive advice
6. Interested in finishing their dental treatment quickly
7. Difficult to come back just to receive advice (if not matched 
with their other treatment/ follow-up visits)
1. Patients would like their dentist to give advice/help in 
tobacco cessation
2. Patients are happy to share their phone number
3. Most are willing to come back for follow-up visits if they 


































Table 5 Major behaviour change techniques (BCT) used and their mechanism of action in the intervention package to support tobacco cessation (based on different stages of 
behaviour change, based on the ‘transtheoretical model’)
Pre-contemplation Contemplation Preparation Action Maintenance
1. BCT used 5.1 Information about health 
consequences
5.1 Information about health 
consequences
9.2 Pros and Cons
5.2 Salience of consequences
1.1 Goal setting (behavior)
1.3 Goal Setting (outcome)
1.5 Review behavior goals
1.7 Review outcome goals
1.2 problem solving
12.3 Avoidance/ reducing expo-
sure to cues for the behaviour
11.2 Reduce negative emotions
1.2 problem solving
12.3 Avoidance/ reducing expo-
sure to cues for the behaviour
11.2 Reduce negative emotions
Mechanism of Action Knowledge Knowledge, belief about conse-
quences
Goals, beliefs about capability Beliefs about capability. environ-
mental context and resources, 
emotion
Beliefs about capability. environ-
mental context and resources, 
emotion
Content used in flip chart 1.Ingredients used in cigarettes 
and ST
2. Health effects of tobacco 
(general health, specific dental 
health)
1. Ingredients used in cigarettes 
and ST
2. Health effects of tobacco
(general health, specific dental 
health)





1. Guidance for cessation
2. Identify social cues and situa-
tions that lead to tobacco use
3.Tips to control the cues
4. Tips to control the withdrawal 
symptoms
1. Guidance for cessation
2. Identify social cues and situa-
tions that lead to tobacco use
3.Tips to control the cues
4. Tips to control the withdrawal 
symptoms
Content used in video 1.Ingredients used in cigarettes 
and ST
2. Health effects of tobacco
1.Ingredients used in cigarette 
and ST
2. Health effects of tobacco
2. BCT used 3.1 Social support (unspecified) 3.1 Social support (unspecified) 3.2 Social support (practical) 3.1 Social support (unspecified)
3.2 Social support (practical)
3.1 Social support (unspecified)
3.2 Social support (practical)
Mechanism of Action Environmental context and 
resources
Environmental context and 
resources
Social influence Social influence Social influence
Content used in flip chart Financial gain over time not 
buying tobacco products. Alter-
native use of saved money
Financial gain over time not 
buying tobacco products. Alter-
native use of saved money
Tips to use friends, family and 
children as sources of encour-
agement in quitting tobacco
1. Tips to use friends, family and 
children as sources of encour-
agement in quitting tobacco
2 Improving public image and 
boosting confidence to attend 
social events because of quitting 
tobacco
1. Tips to use friends, family and 
children as sources of encourage-
ment in quitting tobacco
2. Improving public image and 
boosting confidence to attend 
social events because of quitting 
tobacco
3. BCT used 3.2 Social support (practical) 3.2 Social support (practical)
Mechanism of Action Social influence Social influence
Intervention setting 1. Accessing professional sup-
port for tobacco cessation
2. Supportive environment at 
the dental clinic
3. Delivery of the intervention 
by dentists or dental nurses
1. Accessing professional sup-
port for tobaccocessation
2. Supportive environment at 
the dental clinic
3. Delivery of the intervention 
by dentists or dental nurses
Pharmacological NRT NRT
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providing tobacco cessation support in dental settings. 
Our study also showed that more than 85% of dentists do 
not use any structured or evidence-based approach while 
giving tobacco cessation advice and do not provide any 
further support. Overall, the intervention seemed to be 
feasible if it is short and designed to fit in with the activi-
ties of the dental department of BIRDEM.
In the second stage of our study, we created a tobacco 
cessation behaviour support intervention based on 
brief advice and pharmacotherapy. Following the ‘3 A’ 
approach: dentists first ask about tobacco use and give 
very brief advice to the users. They then assist the patient 
by signposting them to a specially trained dentist or den-
tal nurse who will be designated to provide support using 
the designed intervention.
Similar to our study findings, lack of both training and 
resources for dentists were identified as major challenges 
for providing tobacco cessation support in dental settings 
in other studies. Prakash et  al. (2013) showed that only 
39% of dentists assisted with quitting, and 42% dentists 
had formal training in tobacco cessation in their study 
of three states in USA [59]. A study in a hospital emer-
gency department in Columbia reported that health care 
providers missed opportunities for smoking cessation 
counseling 70% of the time [60]. This situation could 
be improved by providing proper training to dentists 
and creating some organizational support structures. 
Tobacco cessation-related training provision could be 
incorporated within the standard dental curricula.
Following the evidence of the effectiveness of behav-
ioural support combined with pharmacotherapy in 
helping people to quit smoking [49] and successful inte-
gration of a patient-facing flipbook for brief advice in 
SEA settings for smoking [43] and ST cessation [44], 
we considered adopting the same approach. The multi-
component tobacco cessation intervention that we cre-
ated contains (1) a flip book to guide tobacco cessation 
based on appropriate BCTs, (2) a short video showing 
the harmful effects of tobacco to increase awareness, and 
(3) pharmacotherapy (NRT). Other tobacco cessation 
interventions delivered in dental settings have also used 
patient-facing flip books, leaflets and videos as inter-
vention components and some studies used NRT [25]. 
Interventions including advice, assistance, and follow-up 
support, which are effective for the general population, 
are expected to be applicable for people with diabetes 
[20]. In our designed intervention, some health effects 
were specifically tailored to diabetes and particular oral 
diseases, as tailoring helps to fully exploit the teachable 
moment [22]. Exploratory surveys and consultations with 
participants in our study revealed that they agreed with 
this approach and considered it acceptable. Therefore, we 
are expecting to provide the optimum package to help 
people quit tobacco in the dental setting. We could not 
include referral to a quit line or support centre within the 
intervention component as no such services are available 
in Bangladesh.
The study has some limitations. The survey sample 
was based on the number of people with diabetes who 
use tobacco and attended dental department BIRDEM 
agreed to participate within the two-month data collec-
tion period. Secondly, incorporation of a detailed obser-
vation study could have identified aspects to inform the 
health system changes in the current setting and refine 
the intervention further. Most of the BCTs were adapted 
from existing studies. However, the BCTs adapted here 
were validated in South Asian population.
To our knowledge, this is the first study to develop 
a tobacco cessation intervention for and with people 
who have diabetes and use tobacco in a dental setting 
in Bangladesh, using a co-production model. Assessing 
patients’ perceptions of a tobacco cessation interven-
tion, dentists’ current service provision and identifica-
tion of barriers and facilitators in this context, will help 
to find a feasible approach to design a future trial to test 
the effectiveness of the co-produced intervention mate-
rials. Co-production increases the relevance of research 
by ensuring that it reflects the needs, values and inter-
ests of patients and improves the quality of research 
through broadening the range of expert input. The next 
stage of work should focus on designing a feasibility 
trial and training materials. This will create organiza-
tional changes to build both a supportive environment 
for tobacco cessation in the dental setting, and capacity 
building among dental health professionals.
Conclusions
As people with diabetes are more prone to oral diseases, 
and tobacco use has deleterious effects on both condi-
tions, it seems appropriate that the dental professional 
can make the patient aware of the risks of tobacco use 
and provide assistance for tobacco cessation. Incorpora-
tion of tobacco cessation within dental care provides a 
unique opportunity to support people with diabetes to 
stop using tobacco, and hence improving their oral as 
well as general health. Our co-produced tobacco cessa-
tion intervention will be tested for feasibility and effec-
tiveness in a future trial within the dental setting and 
is expected to be helpful in addressing a major health 
challenge.
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